Triazolylated teritiary amine compound or salt thereof
    3.
    发明授权
    Triazolylated teritiary amine compound or salt thereof 失效
    三唑基化三胺化合物或其盐

    公开(公告)号:US5674886A

    公开(公告)日:1997-10-07

    申请号:US199180

    申请日:1994-02-24

    摘要: A triazolylated tertiary amine compound represented by general formula (I) or a salt thereof, having an aromatase inhibitory activity and being useful for preventing and treating breast cancer, mastopathy, endometriosis, prostatomergaly, etc., wherein A represents a single bond, lower alkylene or carbonyl; B represents lower alkyl, aryl, a 5- or 6-membered heterocyclic group, or a bicyclic fused heterocyclic group; D represents aryl, a 5- or 6-membered heterocyclic group, or a bicyclic fused heterocyclic group; and E represents 4H-1,2,4-triazolyl, 1H-1,2,4-triazolyl or 1H-1,2,3-triazolyl.

    摘要翻译: PCT No.PCT / JP92 / 01089 Sec。 371日期1994年2月24日 102(e)1994年2月24日PCT PCT 1992年8月27日PCT公布。 公开号WO93 / 05027 (I)具有芳香酶抑制活性的通式(I)表示的三唑基化叔胺化合物或其盐,可用于预防和治疗乳腺癌,乳腺病,子宫内膜异位症,前列腺素, 等等,其中A表示单键,低级亚烷基或羰基; B表示低级烷基,芳基,5或6元杂环基或双环稠合杂环基; D表示芳基,5或6元杂环基或双环稠合杂环基; E表示4H-1,2,4-三唑基,1H-1,2,4-三唑基或1H-1,2,3-三唑基。

    Azole derivative and pharmaceutical composition thereof
    5.
    发明授权
    Azole derivative and pharmaceutical composition thereof 失效
    唑衍生物及其药物组合物

    公开(公告)号:US5807880A

    公开(公告)日:1998-09-15

    申请号:US619629

    申请日:1996-03-26

    摘要: An azole derivative represented by the following general formula (I) ##STR1## (symbols in the formula have the following meanings; R.sup.1 and R.sup.2 : the same or different from each other and each represents a hydrogen atom, a lower alkyl group or a phenyl group which may be substituted with a halogen atom, A, B and D: the same or different from one another and each represents a group represented by the formula ##STR2## or a nitrogen atom, X and Y: the same or different from each other and each represents a single bond, a methylene group, an oxygen atom, a group represented by a formula S(O).sub.n, or a group represented by the formula ##STR3## R.sup.3 and R.sup.4 : the same or different from each other and each represents a hydrogen atom or a lower alkyl group, and n: 0, 1 or 2), a salt thereof, a hydrate thereof or a solvate thereof. This compound has a function to inhibit steroid 17-20 lyase and is useful as preventive and treating agents for prostatic cancer, prostatic hypertrophy, virilism, breast cancer, mastopathy, histeromyoma, and endometriosis.

    摘要翻译: PCT No.PCT / JP94 / 01593 Sec。 371日期:1996年3月26日 102(e)1996年3月26日PCT 1994年9月28日PCT公布。 出版物WO95 / 09157 日期:1995年4月6日由以下通式(I)表示的唑衍生物(I)(式中的符号具有以下含义:R 1和R 2彼此相同或不同,各自表示氢原子 可以被卤素原子取代的低级烷基或苯基,A,B和D:彼此相同或不同,并且各自表示由下式表示的基团或氮原子,X和 Y:彼此相同或不同,并且各自表示单键,亚甲基,氧原子,由式S(O)n表示的基团或由下式表示的基团:R 3和R 4: 相同或不同,各自表示氢原子或低级烷基,n:0,1或2),其盐,其水合物或其溶剂合物。 该化合物具有抑制类固醇17-20裂解酶的功能,可用作前列腺癌,前列腺肥大,病毒性,乳腺癌,乳腺病,囊胚瘤和子宫内膜异位症的预防和治疗剂。

    Oxazinobenzazole compounds
    7.
    发明授权
    Oxazinobenzazole compounds 失效
    恶嗪环唑化合物

    公开(公告)号:US5278158A

    公开(公告)日:1994-01-11

    申请号:US837252

    申请日:1992-02-14

    CPC分类号: C07D513/04

    摘要: Oxazinobenzazole derivatives represented by the formula (I): ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4, which may be the same or different, each independently represents a hydrogen atom or a lower alkyl group; R.sup.5 and R.sup.6 jointly form, in conjunction with the two adjacent carbon atoms, a substituted or unsubstituted 5- or 6-membered heterocyclic ring having at least two nitrogen atoms and optionally having one or more heteroatom(s) selected from the group consisting of an oxygen atom, a sulphur atom and a nitrogen atom; and m is an integer of 0 or 1, and pharmaceutically acceptable salts thereof. The compounds of the present invention are useful as antispasmodic medicaments.

    摘要翻译: 由式(I)表示的恶唑烷基恶唑衍生物:(*化学结构*)(I)其中R 1,R 2,R 3和R 4可以相同或不同,各自独立地表示氢原子或低级烷基; R 5和R 6与两个相邻的碳原子一起形成取代或未取代的具有至少两个氮原子且任选具有一个或多个选自以下的杂原子的取代或未取代的5-或6-元杂环: 氧原子,硫原子和氮原子; 和m为0或1的整数,及其药学上可接受的盐。 本发明的化合物可用作解痉药物。